Milestone Pharmaceuticals Inc. (MIST) Tops Q3 EPS by 2c
Tweet
Share
E-mailGet Alerts MIST Hot Sheet
Join SI Premium – FREE
Milestone Pharmaceuticals Inc. (NASDAQ: MIST) reported Q3 EPS of ($0.14), $0.02 better than the analyst estimate of ($0.16).
For earnings history and earnings-related data on Milestone Pharmaceuticals Inc. (MIST) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Chevron signed an agreement with Iraq's Basra Oil Company to advance commercial negotiations for West Qurna 2
- Royalty Pharma plc (RPRX) Declares $0.235 Quarterly Dividend; 1.6% Yield
- ACI Worldwide exploring sale of billing division - Reuters
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
